Alnylam Pharmaceuticals faces near-term headwinds from TTR franchise momentum concerns. Click here to read why ALNY stock is ...

Central Pharmaceuticals Limited could face regulatory sanctions, including penalties, the suspension of trading privileges, or even delisting from the stock exchange, as flagged by the company's ...

Square Pharmaceuticals has achieved a significant overseas milestone as its Kenya-based subsidiary reported an operating profit for the first time, less than two years after starting commercial ...

Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA / ACCESS Newswire / ...

The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who ...

Sub-Saharan Africa receives just 2% of global cargo capacity despite exponential population growth and increasing demand for ...

This week’s PPC Pulse covers Google’s Data Manager API, new YouTube Shorts features, and LinkedIn’s Reserved Ads for brand and performance teams.

Cycle Group Holdings Limited will acquire by the pharmaceutical company Applied Therapeutics.

Under the terms of the merger agreement, Cycle will commence a tender offer to acquire all of the outstanding shares of Applied common stock for a per share price of $0.088 per share in cash payable ...

Get the latest Takeda (TAK) stock analysis. Read about risks, future prospects, and why peers may offer better value for ...

The Council and the Parliament have reached a deal on new rules to make the EU’s pharmaceutical sector fairer and more ...

Ltd. and Shenzhen Moyuan Pharmaceuticals Co. Ltd. have synthesized lactate dehydrogenase A (LDHA) inhibitors reported to be useful for the treatment of primary hyperoxaluria.